VANGUARD GROUP INC 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-31 11:04 am Sale | 2025-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 7,125,498 4.920% | -2,255,049 (-24.04%) | Filing |
| 2025-07-29 1:55 pm Sale | 2025-06-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 9,380,547 6.510% | -623,347 (-6.23%) | Filing |
| 2024-02-13 5:08 pm Sale | 2023-12-29 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 10,003,894 7.570% | -386,085 (-3.72%) | Filing |
| 2023-02-09 11:25 am Sale | 2022-12-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 10,389,979 7.900% | -143,630 (-1.36%) | Filing |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 10,533,609 8.010% | 5,820,157 (+123.48%) | Filing |
| 2021-02-10 11:22 am Purchase | 2020-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 4,713,452 5.300% | 4,713,452 (New Position) | Filing |